- Home
- UBCP vs ATYR Comparison
UBCP vs ATYR Comparison
Compare UBCP & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBCP | ATYR |
|---|---|---|
| Founded | 1902 | 2005 |
| Country | United States | United States |
| Employees | N/A | 58 |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 77.0M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | UBCP | ATYR |
|---|---|---|
| Price | $16.26 | $0.83 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $3.67 |
| AVG Volume (30 Days) | 23.4K | ★ 788.8K |
| Earning Date | 05-08-2026 | 05-01-2026 |
| Dividend Yield | ★ 5.73% | N/A |
| EPS Growth | ★ 5.51 | N/A |
| EPS | ★ 1.34 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.58 | N/A |
| P/E Ratio | $12.23 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.47 | $0.64 |
| 52 Week High | $17.34 | $7.29 |
Technical Indicators
Market Signals| Indicator | UBCP | ATYR |
|---|---|---|
| Relative Strength Index (RSI) | 54.55 | 52.37 |
| Support Level | $14.27 | $0.68 |
| Resistance Level | $17.08 | $0.86 |
| Average True Range (ATR) | 0.45 | 0.05 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 49.32 | 67.67 |
Price Performance
Historical ComparisonAbout UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.
About ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).